| Prev Close | 84.91 |
| Open | 76.35 |
| Day Low/High | 75.00 / 85.98 |
| 52 Wk Low/High | 26.56 / 100.77 |
| Volume | 2.34M |
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
77.83
7.08
8.34
NYSE
| Exchange | NYSE |
| Shares Outstanding | 59.94B |
| Market Cap | 5.09B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
The Market Is Setting Up for the Next Big Move
Despite the lackluster action there are some pockets of good stock picking again.
3 Promising Biotech Stocks to Buy on a Market Pullback
Eagle Pharmaceuticals, Biohaven Pharmaceuticals and Acadia Pharmaceuticals are names to consider on a 10% move down in equities.
What's Making This Market So Difficult Is That It's So Lopsided
Even if you are bullish and want to try to ride the uptrend the entry points are extremely difficult.
Biohaven Pharmaceutical Needs More Bottom Development Before Becoming a Buy
You can't rush drugs to market and you can't rush a market bottom.
Anatomy of a Lucrative Biotech Trade
The trade involves using a buy-write option strategy after negative news knocks down a biotech stock into oversold territory.
It's Extremely Tough to Keep Chasing This Market Higher
Market players have one eye on Fed Chair Jerome Powell who is testifying before Congress.
Trading Notes on 21 Stocks I Currently Own
Here are my takes on stocks in biotech and other companies I own right now.
We Have a Market That Has Become a Little Extended
This looks like a normal pause within an uptrend.
Release Your 'Inner Spock' When Investing in Biotech Stocks
Be zen and keep emotions out of investing decisions. It can pay off in higher portfolio returns.
2 Single Hitters That Could Score With the 'Write' Strategy
These stocks look ripe for a buy-write options win.
Potential Trades I'm Looking at on the Fed Decision
A dovish Fed will weaken the dollar, which will weaken gold, and vice versa.